Back to results
US 2022/0186250 A1Published application
Recombinant parvoviral vectors and method of making and use thereof
AssigneeNikegen Limited
InventorsWeidong XIAO, Xiangping YU
Life of this patent
Estimating the term…
Abstract
A parvovirus vectors with a viral genome having a covalently closed end (ccePV vectors), methods for producing such vectors and DNA constructs used for producing such vectors.
Claims25
A duplexed parvovirus particle comprising:
- a parvovirus capsid;
- and
- a vector genome comprising in the 5′ to 3′ direction:
- (a) a parvovirus terminal repeat at the 5′ end;
- (b) a parvovirus terminal repeat at the 3′ end
- (c) a double stranded (DS) DNA domain between the terminal repeats in (a) and (b), the DS-DNA domain comprising a self-complementary first heterologous nucleotide sequence annealed to second heterologous nucleotide sequence;
- and
- (d) a single stranded covalently closed end (SS-CCE) domain between the first heterologous nucleotide sequence and the second heterologous nucleotide sequence, the SS-CCE domain comprising a looped structure;
- wherein the DS domain is not contiguous with a self-annealed stem portion comprising more than 20 contiguous nucleotide base pairs from a mutant inverted terminal repeat (mTR) sequence or a short hairpin DNA (shDNA) sequence, and
- wherein the vector genome is capable of being replicated to form the duplexed parvovirus particle when introduced into a host cell expressing helper functions sufficient for producing the duplexed parvovirus particle.
7 more elements
15-17. (canceled)
19-24. (canceled)
26-28. (canceled)
30-33. (canceled)
35-40. (canceled)
A method for making a self-complementary AAV, comprising:
- (a) providing a plasmid comprising a fragment comprising in a 5′ to 3′ direction:
- (i) a parvovirus terminal repeat comprising an AAV ITR;
- (ii) a promoter operatively linked to a nucleic acid encoding a protein or RNA;
- and (iii) a nuclease cut site in the plasmid;
- (b) providing a DNA fragment comprising at least half of a mITR or at least half of a shDNA;
- (c) providing a host cell comprising one or more helper genes sufficient for replicating a nucleic acid comprising parvovirus terminal repeats flanking a nucleic acid of interest;
- (d) digesting the plasmid with a nuclease enzyme specific for the nuclease cut site under conditions sufficient for linearizing the plasmid, wherein the plasmid is digested in vitro or is digested in the host cell;
- (e) ligating the plasmid to the DNA fragment with a DNA ligase, wherein the plasmid is ligated in vitro or is ligated in the host cell so that a hairpin comprising mTR or shDNA sequences is formed;
- (f) culturing the host cell comprising the plasmid treated according to steps (d) and (t) under conditions suitable for producing parvovirus particles following completion of step (e);
- and
- (g) recovering the parvovirus particles produced in step (f).
8 more elements
A vector genome comprising in the 5′ to 3′ direction:
- (1) a parvovirus terminal repeat at the 5′ end,
- (2) a first regulatory region comprising (a) a promoter region, or (b) a poly A or poly T sequence, or both (a) and (b),
- (3) a first heterologous nucleotide sequence,
- (4) a covalently closed end (CCE) domain,
- (5) a second heterologous nucleotide sequence,
- (6) a first regulatory region comprising (a) a promoter region, or (b) a poly A or poly T sequence, or both (a) and (b), and
- (7) a parvovirus terminal repeat at the 3′ end;
- wherein the first regulatory sequence is complementary to the second heterologous sequence and forms a double-stranded region (DS-domain) in the vector genome,
- wherein the CCE domain is (a) a single covalent bond connecting the first heterologous nucleotide sequence and the second nucleotide sequence, or (b) a single stranded DNA region, and
- wherein the vector genome is capable of producing a double-stranded (DS)-RNA molecule from the DS-domain of the vector genome.
7 more elements
Dependencies are inferred from the claim text.